欧洲粒子治疗网络十年:里程碑与未来方向
本文总结欧洲粒子治疗网络(EPTN)自2015年成立、2017年成为ESTRO任务组以来的十年历程。文章概述其在提升欧洲粒子治疗可见度、协调性与数据稳健性方面的作用,并结合欧洲粒子治疗中心(尤其质子治疗设施)快速扩张的背景,讨论实施该技术的经济与临床挑战及未来方向。
要点
- EPTN于2015年成立,2017年成为ESTRO任务组,旨在整合粒子治疗与欧洲放疗共同体。
- 过去十年EPTN着力提升欧洲粒子治疗的可见度、协调性与数据稳健性。
- 文章结合欧洲粒子治疗中心快速扩张,讨论经济与临床挑战及未来方向。
核心结论
- EPTN通过十年工作支持粒子治疗在欧洲成为癌症治疗武器库的组成部分,并明确了未来推进的关键挑战。
研究设计与样本
- 本文为综述性文章,总结EPTN十年历程,检索范围与文献纳入方法原文未报告。
主要发现
- EPTN于2015年成立,2017年成为ESTRO任务组;过去十年致力于提升欧洲粒子治疗的可见度、协调性与数据稳健性。
- 文章结合欧洲粒子治疗中心(尤其质子治疗设施)的快速扩张进行总结,并讨论实施该技术的经济与临床挑战。
临床怎么用
- 文章为网络发展总结,未给出可直接用于临床决策的具体推荐条款或数值标准。
局限性
- 本文为EPTN十年工作总结与展望,原文未报告系统检索方法与定量数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The European Particle Therapy Network (EPTN) was established in 2015 to promote professional collaboration and foster clinical and research partnerships in particle therapy across Europe. In 2017, it became a Task Force of the European Society for Radiotherapy and Oncology (ESTRO), with the goal of integrating particle therapy within the broader European radiotherapy community. As particle therapy represents only one component of modern radiation oncology, its development must be aligned with advances in other radiotherapy techniques, multidisciplinary cancer research, and comprehensive patient care. Particle therapy offers unique opportunities to optimize treatment for selected indications and to conduct high-quality research within coordinated European frameworks. Over the past decade, the EPTN has worked to enhance visibility, coordination, and data robustness across Europe, supporting the establishment and consolidation of particle therapy as an integral element of the cancer treatment arsenal. This article summarizes the EPTN's 10-year journey in the context of the rapid expansion of European particle therapy centres-particularly proton therapy facilities-while addressing the economic and clinical challenges associated with implementing this advanced technology. Finally, we outline the Network's future directions and the key challenges ahead in advancing particle therapy across Europe.
引用
- Weber DC, Langendijk JA, Safai S, et al. The European particle therapy network at 10 years: milestones achieved and the road ahead. Radiother Oncol. 2026. PMID: 42815777. doi:10.1016/j.radonc.2026.111797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。